Related Experiment Videos
[Effect of cefodizime on the immune system: in vitro studies]
Abstract:
Cefodizime is a broad-spectrum cephalosporin with high efficacy, especially in experimental infections. The in vivo activity may be partly due to an immunomodulatory effect. Macrophages in cefodizime-treated mice showed enhanced activity (chemiluminescence, IL-1-synthesis, IFN-synthesis). The number of PFC increased during the treatment with cefodizime. The spleen cells of these mice showed elevated responses to dextransulfate and LPS but not to ConA or PHA.
Insights
Cefodizime, a broad-spectrum cephalosporin, enhances macrophage activity and immune responses in mice. This immunomodulatory effect contributes to its high efficacy in treating experimental infections.
Area of Science:
- Immunology
- Microbiology
- Pharmacology
Context:
- Cefodizime is a broad-spectrum cephalosporin antibiotic.
- Its efficacy in experimental infections is well-established.
- The underlying mechanisms of its in vivo activity are under investigation.
Purpose:
- To investigate the immunomodulatory effects of cefodizime in vivo.
- To assess the impact of cefodizime on macrophage function.
- To evaluate the influence of cefodizime on B-cell responses.
Summary:
- Cefodizime treatment in mice led to enhanced macrophage activity, evidenced by increased chemiluminescence, interleukin-1 (IL-1) synthesis, and interferon (IFN) synthesis.
- The number of plaque-forming cells (PFC) increased during cefodizime treatment.
- Spleen cells from treated mice exhibited heightened responses to dextran sulfate and lipopolysaccharide (LPS), but not to concanavalin A (ConA) or phytohemagglutinin (PHA).
Impact:
- Cefodizime exhibits immunomodulatory properties beyond its antimicrobial activity.
- These effects may contribute to the observed high efficacy of cefodizime in experimental infections.
- Findings suggest potential therapeutic applications leveraging cefodizime's immune-enhancing capabilities.